⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14052106 | 1.00 | — | — | |
| SCHEMBL13667815 | 0.91 | — | — | |
| SCHEMBL12454850 | 0.88 | — | — | |
| SCHEMBL12295266 | 0.87 | — | — | |
| SCHEMBL13667495 | 0.84 | — | — | |
| SCHEMBL15607071 | 0.82 | — | — | |
| SCHEMBL15605954 | 0.78 | — | — | |
| SCHEMBL15084442 | 0.76 | — | — | |
| SCHEMBL12454575 | 0.76 | — | — | |
| SCHEMBL13667909 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8008264-B2 | 1′-substituted carba-nucleoside analogs for antiviral treatment | GILEAD SCIENCES, INC. (US) | 2011-08-30 | — | — | US | disclosed |